Inspiron All-commers

One-Year Clinical Outcome of Inspiron Stent in All-Comers Population (Analysis from 790 Consecutive Patients).
The goal of this study was to evaluate the performance of the InspironTM coronary stent (Scitech Medical™, Goiás, Brazil). The InspironTM sirolimus-eluting stent uses an ultrathin L-605 cobalt-chromium alloy with a 75 μm strut thickness platform coated with an abluminal biodegradable polymer. The polymer is eliminated from the body through the tricarboxylic acid cycle in 6–9 months, releasing 80% of the drug within 30 days after its deployment.

INSPIRON Coronary Sirolimus Eluting Stent from SCITECH Medical received CE Mark approval.

INSPIRON Coronary Sirolimus Eluting Stent from SCITECH Medical received CE Mark approval.
INSPIRON is a 3rd generation Drug Eluting Stent designed to create a fast and homogeneous endothelialization. Its design, material (CoCr), thin struts (75 μm) and delivery system gives it good navigability, flexibility, good crossover profile, moderate radiopacity and high balloon rupture pressure. Its abluminal coating is composed of a mixture of PLA and PLGA polymers and a low Sirolimus dosage resulting in a moderate drug elution profile (60% in 10 days and 100% in 45 days), complete coating degradation between 6 and 9 months and in a fast and homogeneous endothelialization.